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Tritiated tetracycline was actively accumulated in inverted membrane vesicles prepared from Escherichia 
coli W3104nf, which has a transposon, TnlO, on the plasmid, R388, by means of a protonmotive force when 
NADH was added as an energy source. The tetracycline accumulation was reduced to about one-half the 
full value on the addition of a cation/proton-exchange ionophore, nigericin. In contrast, remarkable stimu- 
lation of the tetracycline accumulation was observed with a K+-specific ionophore, valinomycin. The accu- 
mulation of [3H]tetracycline could also be driven by an artificially imposed interior-acidic pH gradient 
(ApH), but not, however, by an artificially imposed interior-positive membrane potential (Aw). These results 
strongly indicate that the plasmid-encoded tetracycline transport was mainly due to an electrically neutral 
proton/tetracycline antiport system. 
Tetracycline resistance Tetracycline transport 
1. INTRODUCTION 
The tetracyclines are broad spectrum antibiotics. 
Their bacteriostatic action is due to their inhibition 
of protein synthesis on ribosomes. Bacterial 
resistance to tetracyclines is widespread; especially 
in the Enterobacteriaceae, and is commonly 
specified by plasmids (reviews [1,2]). The 
resistance is generally induced by subinhibitory 
amounts of tetracyclines [3]. The tetracycline 
resistance determinants are classified into 4 classes 
on the basis of their DNA-DNA hybridization as 
well as their levels of resistance to tetracyclines and 
their hydrophobic analogs [4]. Among them, class 
B or TnlO-type determinants, which show the 
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Abbreviations: ANS, %anilino-1-naphthalenesulfonate; 
CCCP, carbonyl cyanide m-chlorophenylhydrazone; 
ApH and A+, pH gradient and electrical potential, 
respectively 
Inverted membrane vesicle (Escherichia coli) 
highest level of resistance to tetracyclines, occur 
most frequently [5]. The 2 kinds of proteins 
associated with the resistance, i.e. the specific in- 
ner membrane protein (Tet protein) with an ap- 
parent molecular mass of 36 kDa [6] and the 
repressor protein of 23 kDa [7], are encoded on 
TnlO. The nucleotide sequence [8,9], organization 
[7] and regulation of expression [lo] of the genes 
involved have been reported. The other plasmid- 
mediated determinants of tetracycline resistance 
were also shown to produce inner membrane pro- 
teins similar to the Tet protein [ 11,121. 
The resistance is related to a decrease in 
tetracycline accumulation [13,14]. Energy- 
dependent efflux of tetracycline was proposed by 
Levy and McMurry 1151 on the basis of an energy- 
dependent decrease in accumulation of the drug in 
resistant cells and the energy-dependent uptake of 
tetracycline by inverted membrane vesicles 
prepared from resistant cells [ 161. This active ef- 
flux was assumed to be a function of the Tet pro- 
tein, however, direct evidence of this has not yet 
been reported. 
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Here, we report the nature of the driving force 
of the tetracycline efflux system of TnlO-bearing 
tetracycline resistant E. coli using inverted mem- 
brane vesicles. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains and growth conditions 
The E. coli K-12 derivative strains, W3104Tif 
(galTi2, X-, rifampicin resistance) and W3104’“/ 
R388::TnlO, were used in this study as sensitive 
and resistant strains to tetracycline, respectively. 
The TnlO-bearing plasmid, R388::TnlO, encodes 
the resistance to trimetoprim and sulfonamide in 
addition to that to tetracycline. 
These strains were cultured in medium A [16] 
supplemented with 0.2% glucose and 0.1% 
casamino acid with vigorous shaking at 37°C. In 
the case of the resistant cells, the medium was fur- 
ther supplemented with 4 pg tetracycline per ml for 
induction of the tetracycline resistance. 
2.2. preparation of inverted membrane vesicles 
Inverted membrane vesicles were prepared from 
cells lysed in a French pressure cell according to 
McMurry et al. [16]. The vesicles were then frozen 
in dry ice/ethanol and stored at - 80°C. 
2.3. Tetracycline uptake by the vesicles 
Tetracycline uptake was assayed as described by 
McMurry et al. [16] with some modifications. 
Vesicles were thawed and diluted to 7 mg protein 
per ml in 50 mM KPOd/lO mM MgS04, pH 7.5, at 
4°C unless otherwise stated, and then the suspen- 
sion was put into glass tubes followed by prein- 
cubation at 30°C. To 45 ~1 of the same buffer in 
a small glass tube, 13H]tetracycline was added to a 
final concentration of 2/1M, with or without p- 
NADH (at a final concentration of 2.5 mM), and 
with or without an ionophore, as described in the 
text. The ionophores were used at the following 
concentrations: CCCP, 10 PM; valinomycin, 
2 pg/ml; nigericin, 2 pg/ml. After 20 min prein- 
cubation at 3O”C, 5 ~1 vesicles was added to each 
mixture followed by agitation by means of hand 
shaking. At various times, samples were mixed 
with 2 ml of 0.1 M LiCl/O.l M KP04, pH 7.5, 
unless otherwise stated, followed by altering 
through Millipore HAWP 0.45 pm pore mem- 
brane filters and washing twice with 2 ml of the 
same buffer, Radioactivity remaining on the filters 
was measured with a liquid scintillation counter. 
2.4. Other procedures 
ANS fluorescence was measured as described by 
Kobayashi et al. [17] with a fluorescence spec- 
trophotometer (Hitachi MPF4) with excitation at 
370 nm and emission at 480 nm. Protein was 
determined by the method of Lowry et al. [18] with 
bovine serum albumin as a standard. 
2.5. Reu~e~ts 
t3H]Tetracycline was purchased from New 
EngIand Nuclear. Valinomycin, nigericin and 
CCCP were obtained from Sigma. ANS was pur- 
chased from Wako, Japan. /3-NADH was pur- 
chased from Oriental Yeast, Japan. 
3. RESULTS AND DISCUSSION 
The inverted membrane vesicles prepared from 
the TnlO-bearing tetracycline resistant cells 
showed NADH-dependent uptake of [3H]tetracy- 
cline (fig.lA), while the vesicles prepared from 
isogenic sensitive cells did not show such tetra- 
cycline uptake (fig.lB). This indicates that the 
NADH-dependent tetracycline uptake system was 
encoded by the resistance determinant as reported 
INCUBATION TIME (MIN.) 
Fig.1. NADH-dependent accumulation of [3H]- 
tetracycline in inverted membrane vesides prepared 
from resistant (A) and sensitive (B) strains. The uptake 
of [3H]tetracycline was assayed in the presence (0) and 
absence (e) of NADH, and in the presence of NADH 
and various ionophores (valinomy~in, A ; nigericin, A ; 
CCCP, x) or ethanol (0) as described in section 2. 
O.Sal of ethanolic solutions of the ionophores and 
ethanoi were added. 
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by McMurry et al. [16]. They showed that the 
tetracycline uptake by inverted membrane vesicles 
prepared from resistant cells was inhibited by the 
addition of 2,4-dinitrophenol, and thus they con- 
cluded that the resistant cells should possess an 
energy-dependent efflux system for tetracycline. 
We also observed that NADH-driven uptake of 
tetracycline was completely inhibited by the addi- 
tion of a proton conductor, CCCP. This clearly in- 
dicates that this uptake system was driven by a pro- 
tonmotive force. This observation was consistent 
with the results for intact cells reported by Curiale 
et al. [ 191, who reported that the level of accumula- 
tion of tetracycline in TnlO-bearing cells was 
remarkably stimulated by the addition of CCCP. 
To examine the nature of the driving force of 
this uptake system, we used 2 ionophores, 
valinomycin and nigericin. Under the experimental 
conditions in which the membrane vesicles were 
energized by the NADH supplied in the potassium 
phosphate buffer, it was expected that valinomycin 
should dissipate the membrane potential (A#) by 
mediating electrogenic potassium influx, and 
nigericin should dissipate the chemical gradient of 
protons (ApH) through electrically neutral ex- 
change of K+ and H+. The effects of these 
ionophores on A# and ApH were examined on the 
basis of the changes in fluorescence of ANS (for 
A$) and quinacrine (for ApH). The use of such in- 
direct assays for A$ and ApH is widely accepted, 
although the quantitative relationships between A$ 
or ApH and the fluorescence changes of such 
indicators remain unclear. The fluorescence 
quenching of quinacrine by NADH indicated the 
formation of a respiration-dependent interior- 
acidic proton gradient. The quenching was com- 
pletely prevented by nigericin. In contrast, the 
degree of quenching was drastically increased by 
valinomycin, probably due to stimulation of 
respiration-driven proton uptake (not shown). 
Fluorescence enhancement of ANS, used as a 
measure of the interior-positive membrane poten- 
tial, was detected with dl-lactate as an energy 
source, because the fluorescence change of ANS 
could not be detected in a NADH solution because 
of overlapping of the wavelength of the 
fluorescence of ANS and that of NADH. dl- 
Lactate-driven fluorescence enhancement of ANS 
was completely prevented by valinomycin, 
however, enhancement of ANS fluorescence was 
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still observed in the presence of nigericin (not 
shown). 
The effects of valinomycin and nigericin on the 
energy-dependent accumulation of tetracycline in 
inverted membrane vesicles prepared from 
TnlO-bearing cells are shown in fig.lA. 
Valinomycin showed no inhibition of [3H]- 
tetracycline accumulation. Instead, it rather ac- 
celerated the accumulation, indicating that the 
accumulation did not require a membrane poten- 
tial. On the other hand, nigericin hindered the 
NADH-induced accumulation of [3H]tetracycline, 
a level of only about one-half the full value being 
attained. Such behavior of the [3H]tetracycline ac- 
cumulation apparently paralleled the behavior of 
the pH gradient when nigericin or valinomycin was 
added. These results strongly indicated that the 
driving force of [3H]tetracycline accumulation in 
the inverted membrane vesicles was the proton gra- 
dient across the membrane (interior acidic). 
To investigate whether ApH alone can drive the 
[3H]tetracycline accumulation or not, we per- 
formed the following experiments using an ar- 
tificially imposed ApH and A$. As shown in fig.2, 
0 10 20 30 40 50 60 
INCUBATION TIME (SEC.) 
Fig.2. Accumulation of [3H]tetracycline in inverted 
membrane vesicles driven by an artificial ApH (interior 
acidic). Vesicles were prepared in 50 mM KPO4 buffer 
from resistant cells and then diluted IO-fold in 50 mM 
Tris-HCl/lO mM MgS04 (pH 7.5) containing [3H]- 
tetracycline (2 pM), followed by incubation at 30°C for 
2 min before nigericin was added. Starting from the 
addition of nigericin, the suspension was incubated at 
30°C for the indicated periods, and then (3H]tetracycline 
transport was stopped by dilution of the suspension with 
2 ml of 0.1 M LiWO.1 M Tris-HCI buffer (pH 7.5) 
(0). Accumulated [3H]tetracycline was assayed as 
described in section 2. As a control, the assay was 
performed in the absence of nigericin 
Volume 193, number 2 FEBS LETTERS December 1985 
when nigericin was added to a potassium-pre- 
loaded vesicle suspension, a rapid burst of [3H]- 
tetracycline accumulation was observed that cor- 
responded to the rapid generation of an artificial 
interior-acidic proton gradient (ApH) resulting 
from an electrically neutral K+/H+ exchange 
mediated by nigericin. 
On the other hand, the valinomycin-induced 
interior-positive membrane potential, which was 
generated by valinomycin-mediated K+ influx into 
Tris-preloaded vesicles, could not drive the 
[3H]tetracycline transport (fig.3A), although 
valinomycin-induced generation of an artificial 
membrane potential was certainly detectable with 
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Fig.3. Effect of an artificially imposed membrane 
potential on [3H]tetracycline transport in inverted 
membrane vesicles. Inverted membrane vesicles were 
prepared from resistant cells in 50 mM KPOd buffer (pH 
6.6) and then diluted with excess 50 mM Tris-HCl buffer 
(pH 7.5), followed by centrifugation at 150000 x g for 
1 h at 4°C. Then the pellet was resuspended in 50 mM 
Tris-HCl buffer (pH 7.5) to a concentration of 7 mg 
protein per ml, followed by incubation for 2 h at 4°C. 
(A) [3H]Tetracycline accumulation. At zero time, 
vesicles prepared as above were diluted lo-fold in 
50 mM KPOd/lO mM MgS04 buffer (pH 7.5) 
containing [3H]tetracycline (2 PM) at 30°C. After 
incubation for 2 min, valinomycin was added to the 
mixture (indicated by the arrow), followed by incubation 
for the indicated periods (0). The accumulation of 
[3H]tetracycline was measured at different times as 
described in section 2. As a control, valinomycin was 
omitted (0). (B) Generation of an artificial membrane 
potential. Vesicles were diluted 200-fold in 50 mM 
KP04/10 mM MgS04 buffer (pH 7.5) in a cuvette, 
followed by the addition of ANS to a final concentration 
of 2pg/ml. At the time indicated by the arrow, 
valinomycin was added to the suspension, and then the 
change in fluorescence intensity of ANS was followed in 
the absence (a) and presence (b) of CCCP as described 
in section 2. 
Therefore, it is obvious that the plasmid- 
encoded [3H]tetracycline transport could be driven 
by an artificially imposed ApH but not by an ar- 
tificially imposed A$. These results confirmed the 
conclusion that the driving force of the 
[3H]tetracycline transport is the proton gradient 
(ApH). This conclusion also suggested that the 
[3H]tetracycline transport was carried out by an 
electrically neutral antiport system of protons and 
a cationic form of the tetracycline. If this is the 
case, the efflux of tetracycline in intact cells should 
only occur when the medium pH is lower than the 
intracellular pH. We found that the level of 
resistance of the TnlO-bearing strain to 
tetracycline increased with a decrease in the 
medium pH of from 8.0 to 6.0, although the 
tetracycline susceptibility of the wild strain re- 
mained unchanged (in preparation). 
It remains unclear why [3H]tetracycline was still 
accumulated in the vesicles, about one-half the full 
value being attained, even in the presence of 
nigericin (fig. lA), although the NADH-induced 
proton gradient (ApH) was negligible under these 
conditions. There are 2 possible explanations for 
this. One of them is that the tetracycline transport 
system can gain some protons in competition with 
nigericin. The other possibility is that the number 
of protons translocated by the tetracycline carrier 
is not equal to that of tetracycline molecules, so the 
system can also be driven electrically even though 
the efficiency of the membrane potential as a driv- 
ing force for tetracycline transport is less than that 
of the proton gradient. An example of the latter 
case is the Na+/H+ system in E. co/i [20]. The 
Na+/H+ antiport system can be driven by ApH 
alone as well as A+ alone under certain conditions, 
thus it is believed that the system includes an elec- 
trogenic exchange mechanism. If the tetracycline 
transport system is also driven by a membrane 
potential, the efficiency should be much less than 
that of a proton gradient because the addition of 
valinomycin to respiring vesicles rather accelerated 
the accumulation of a tetracycline. 
The Tet protein encoded by the tetracycline 
resistance determinant is apparently responsible 
for the efflux of tetracyclines. The Tet protein has 
the unique characteristic that its structural gene 
consists of 2 domains which complement each 
other, intracistronically [19]. The 2 domains of the 
Tet protein may represent 2 distinct active sites for 
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protons and tetracycline, respectively. Further ex- 
periments are being performed to determine the 
characteristics of the efflux system for 
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